Literature DB >> 18836993

Techniques to improve the direct ex vivo detection of low frequency antigen-specific CD8+ T cells with peptide-major histocompatibility complex class I tetramers.

Pratip K Chattopadhyay1, J Joseph Melenhorst, Kristin Ladell, Emma Gostick, Phillip Scheinberg, A John Barrett, Linda Wooldridge, Mario Roederer, Andrew K Sewell, David A Price.   

Abstract

The ability to quantify and characterize antigen-specific CD8+ T cells irrespective of functional readouts using fluorochrome-conjugated peptide-major histocompatibility complex class I (pMHCI) tetramers in conjunction with flow cytometry has transformed our understanding of cellular immune responses over the past decade. In the case of prevalent CD8+ T cell populations that engage cognate pMHCI tetramers with high avidities, direct ex vivo identification and subsequent data interpretation is relatively straightforward. However, the accurate identification of low frequency antigen-specific CD8+ T cell populations can be complicated, especially in situations where T cell receptor-mediated tetramer binding occurs at low avidities. Here, we highlight a few simple techniques that can be employed to improve the visual resolution, and hence the accurate quantification, of tetramer binding CD8+ T cell populations by flow cytometry. These methodological modifications enhance signal intensity, especially in the case of specific CD8+ T cell populations that bind cognate antigen with low avidities, minimize background noise, and enable improved discrimination of true pMHCI tetramer binding events from nonspecific uptake.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18836993      PMCID: PMC2586006          DOI: 10.1002/cyto.a.20642

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  48 in total

1.  Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation.

Authors:  Michael R Betts; Jason M Brenchley; David A Price; Stephen C De Rosa; Daniel C Douek; Mario Roederer; Richard A Koup
Journal:  J Immunol Methods       Date:  2003-10-01       Impact factor: 2.303

2.  The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration.

Authors:  Michael R Betts; David A Price; Jason M Brenchley; Karin Loré; F Javier Guenaga; Anna Smed-Sorensen; David R Ambrozak; Stephen A Migueles; Mark Connors; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

Review 3.  Seventeen-colour flow cytometry: unravelling the immune system.

Authors:  Stephen P Perfetto; Pratip K Chattopadhyay; Mario Roederer
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

4.  Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2.

Authors:  G F Gao; J Tormo; U C Gerth; J R Wyer; A J McMichael; D I Stuart; J I Bell; E Y Jones; B K Jakobsen
Journal:  Nature       Date:  1997-06-05       Impact factor: 49.962

5.  HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.

Authors:  D N Garboczi; D T Hung; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

6.  Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance.

Authors:  Alfred Zippelius; Pascal Batard; Verena Rubio-Godoy; Gilles Bioley; Danielle Liénard; Ferdy Lejeune; Donata Rimoldi; Philippe Guillaume; Norbert Meidenbauer; Andreas Mackensen; Nathalie Rufer; Norbert Lubenow; Daniel Speiser; Jean-Charles Cerottini; Pedro Romero; Mikaël J Pittet
Journal:  Cancer Res       Date:  2004-04-15       Impact factor: 12.701

7.  Phenotypic analysis of antigen-specific T lymphocytes.

Authors:  J D Altman; P A Moss; P J Goulder; D H Barouch; M G McHeyzer-Williams; J I Bell; A J McMichael; M M Davis
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

Review 8.  Tricks with tetramers: how to get the most from multimeric peptide-MHC.

Authors:  Linda Wooldridge; Anna Lissina; David K Cole; Hugo A van den Berg; David A Price; Andrew K Sewell
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

9.  Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy.

Authors:  S Valitutti; S Müller; M Dessing; A Lanzavecchia
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

10.  Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells.

Authors:  Petra Wolint; Michael R Betts; Richard A Koup; Annette Oxenius
Journal:  J Exp Med       Date:  2004-03-29       Impact factor: 14.307

View more
  31 in total

1.  T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy.

Authors:  Elaine M Sloand; J Joseph Melenhorst; Zachary C G Tucker; Loretta Pfannes; Jason M Brenchley; Agnes Yong; Valeria Visconte; Colin Wu; Emma Gostick; Phillip Scheinberg; Matthew J Olnes; Daniel C Douek; David A Price; A John Barrett; Neal S Young
Journal:  Blood       Date:  2010-11-19       Impact factor: 22.113

Review 2.  A chromatic explosion: the development and future of multiparameter flow cytometry.

Authors:  Pratip K Chattopadhyay; Carl-Magnus Hogerkorp; Mario Roederer
Journal:  Immunology       Date:  2008-12       Impact factor: 7.397

3.  Soluble MHC-peptide complexes: tools for the monitoring of T cell responses in clinical trials and basic research.

Authors:  Philippe Guillaume; Danijel Dojcinovic; Immanuel F Luescher
Journal:  Cancer Immun       Date:  2009-09-25

Review 4.  The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma.

Authors:  Ann M Moormann; Cynthia J Snider; Kiprotich Chelimo
Journal:  Curr Opin Infect Dis       Date:  2011-10       Impact factor: 4.915

5.  Early immunologic correlates of HIV protection can be identified from computational analysis of complex multivariate T-cell flow cytometry assays.

Authors:  Nima Aghaeepour; Pratip K Chattopadhyay; Anuradha Ganesan; Kieran O'Neill; Habil Zare; Adrin Jalali; Holger H Hoos; Mario Roederer; Ryan R Brinkman
Journal:  Bioinformatics       Date:  2012-02-29       Impact factor: 6.937

6.  MHC-derived allopeptide activates TCR-biased CD8+ Tregs and suppresses organ rejection.

Authors:  Elodie Picarda; Séverine Bézie; Vanessa Venturi; Klara Echasserieau; Emmanuel Mérieau; Aurélie Delhumeau; Karine Renaudin; Sophie Brouard; Karine Bernardeau; Ignacio Anegon; Carole Guillonneau
Journal:  J Clin Invest       Date:  2014-05-01       Impact factor: 14.808

7.  Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clusters.

Authors:  Cécile Gouttefangeas; Cliburn Chan; Sebastian Attig; Tania T Køllgaard; Hans-Georg Rammensee; Stefan Stevanović; Dorothee Wernet; Per thor Straten; Marij J P Welters; Christian Ottensmeier; Sjoerd H van der Burg; Cedrik M Britten
Journal:  Cancer Immunol Immunother       Date:  2015-02-18       Impact factor: 6.968

8.  Amine-reactive dyes for dead cell discrimination in fixed samples.

Authors:  Stephen P Perfetto; Pratip K Chattopadhyay; Laurie Lamoreaux; Richard Nguyen; David Ambrozak; Richard A Koup; Mario Roederer
Journal:  Curr Protoc Cytom       Date:  2010-07

Review 9.  Cytometry: today's technology and tomorrow's horizons.

Authors:  Pratip K Chattopadhyay; Mario Roederer
Journal:  Methods       Date:  2012-02-25       Impact factor: 3.608

10.  Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses.

Authors:  Yun Lin; Humilidad F Gallardo; Geoffrey Y Ku; Hao Li; Gregor Manukian; Teresa S Rasalan; Yinyan Xu; Stephanie L Terzulli; Lloyd J Old; James P Allison; Alan N Houghton; Jedd D Wolchok; Jianda Yuan
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.